Imuno Therapeutics logo

Imuno Therapeutics

Identifying true targets in oncology and autoimmune disorders

13 employees · est. 2020 · Leiden, The Netherlands

VS
Numab Therapeutics AG logo

Numab Therapeutics AG

Multi-specific antibodies that enable the pursuit of novel therapeutic strategies.

68 employees · est. 2011 · Horgen, Switzerland

Numab Therapeutics AG is the older company (2020 vs 2011); Numab Therapeutics AG is the larger of the two.

Side-by-Side Comparison

Imuno Therapeutics Numab Therapeutics AG
Founded
2020 2011 older
Headquarters
Leiden, The Netherlands Horgen, Switzerland
Employees
13 68 larger
Industry
Health Care, Health and Wellness Biopharma, Biotechnology, Health Care
Funding Stage
Seed Series C
Total Funding
Not tracked yet $122.00M
Funding Rounds
Not tracked yet 3
Services
Development of next-generation immunotherapies, Engineering precision-targeted intracellular antigen therapies, Partnering for immunotherapy advancements Not tracked yet
Target Customers
Patients with hard-to-treat diseases, Oncology and autoimmune disease communities, Biotechnology and pharmaceutical partners Not tracked yet
Taxonomy
Structure-based Discovery, Cancer-specific Epitopes, Therapeutic Targeting, Novel Therapeutic Strategies, Oncology, Autoimmune Disorders, Cross-reactive Epitopes, In-vitro Safety Studies, Personalized Medicine, Tumor-specific Therapy, Drug Discovery, Bioinformatics, Epitope Identification, Safe Therapies Development Multi-specific Antibodies, Therapeutic Strategies, Immunotherapies, Inflammation, Cancer, Drug Discovery, Pipeline, Precision Medicine, Atopic Dermatitis, Therapeutic Design, Patient Benefits, Innovation, Biopharmaceuticals
Website
imunotx.com numab.com
Imuno Therapeutics logo

About Imuno Therapeutics

Imuno Therapeutics, founded in 2020 and headquartered in The Netherlands, is at the forefront of leveraging machine learning for drug discovery in the fields of oncology and autoimmune disorders. Their slogan, "Identifying true targets in oncology and autoimmune disorders," encapsulates their innova...

Numab Therapeutics AG logo

About Numab Therapeutics AG

Numab Therapeutics AG is a Swiss-based biopharmaceutical company founded in 2011. The company specializes in developing multi-specific antibody-based immunotherapies for inflammation and cancer. With a proprietary platform called λ-Cap™ and MATCH™, Numab has a unique advantage in overcoming historic...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Imuno Therapeutics and Numab Therapeutics AG — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Imuno Therapeutics and Numab Therapeutics AG — by email.

Frequently Asked Questions

Imuno Therapeutics — Identifying true targets in oncology and autoimmune disorders. Numab Therapeutics AG — Multi-specific antibodies that enable the pursuit of novel therapeutic strategies.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Imuno Therapeutics has raised undisclosed funding while Numab Therapeutics AG has raised $122.00M.
Imuno Therapeutics and Numab Therapeutics AG operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Imuno Therapeutics with someone else

Start typing a company name or domain.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy